Novavax (NVAX) PT Lowered to $35 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.65 --0%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 2
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 2
Join SI Premium – FREE
H.C. Wainwright analyst Vernon Bernardino lowered the price target on Novavax (NASDAQ: NVAX) to $35.00 (from $110.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Downgrades HubSpot Inc (HUBS) to Equalweight
- South Bow Corporation (SOBO) PT Raised to $34 at Barclays
- Procore Technologies, Inc (PCOR) PT Raised to $85 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
